Application Notes

Tuesday, June 23, 2015
Metrics Contract Services Invests In Equipment
Metrics Contract Services (Metrics) has purchased state-of-the-art analytical laboratory equipment to better serve pharmaceutical clients whose drug products now must undergo heightened elemental ... Read More
Tuesday, June 23, 2015
eClinicalOS™ Mobile App Breaks New Ground for Clinical Researchers
Study Connect™, a new mobile app from Merge eClinical, allows eClinicalOS (eCOS) users to perform a wide array of clinical trial management functions from their iOS-based mobile devices. Read More
Friday, June 19, 2015
Intas Launches RAZUMAB
Intas Pharmaceuticals has launched RAZUMAB™, its biosimilar to Lucentis® (Ranibizumab). Intas is the first company globally to develop and launch a biosimilar version of Ranibizumab. Read More
Friday, June 19, 2015
Alexza Amends ADASUVE® Commercial Partnership Agreements
Alexza Pharmaceuticals has updated and amended its ADASUVE® (Staccato® loxapine) commercial partnerships with Grupo Ferrer Internacional, S.A. and Teva Pharmaceutical Industries Ltd. Read More
Friday, June 19, 2015
Survey: Biopharmaceutical Deals to Set a Record in 2015
A survey of biopharmaceutical dealmakers by Campbell Alliance, the consulting firm of inVentiv Health, suggests that 2015 will set a new record for mergers and acquisitions and licensing of ... Read More
Friday, June 19, 2015
FDA Takes Action to Protect Consumers
The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, took action against more than 1,050 websites that illegally sell potentially dangerous... Read More
Friday, June 19, 2015
Senator Probes Retailers on Dubious 'Brain' Supplements
A high-ranking Senate Democrat is probing retailers and online companies about sales of dubious dietary supplements, especially those promising seniors protection from memory loss, dementia and other ... Read More
Friday, June 19, 2015
Sandoz Launches Glatopa
Sandoz, a Novartis company, has announced the US launch of GlatopaTM, the first generic version of Teva's Copaxone® (glatiramer acetate injection) 20 mg/ml one-time-daily multiple sclerosis therapy. Read More
Thursday, June 18, 2015
SGS Life Science Services Opens New French Laboratory
SGS Life Science Services has announced the planned opening of its new bio/pharmaceutical quality control laboratory at Villeneuve La Garenne, a Paris suburb, replacing an existing facility in Clichy. Read More
Thursday, June 18, 2015
Allergan Acquires Kythera
Allergan is buying Kythera Biopharmaceuticals for about $2.1 billion, adding a drug that destroys fat cells and eliminates the cosmetic condition referred to as "double chin". Read More
Thursday, June 18, 2015
Catalent Expands Packaging Capabilities
Catalent has expanded its Singapore facility, which recently received GMP approval from the Health Science Authority, to provide secondary packaging and labeling capabilities. Read More
Thursday, June 18, 2015
Dwarfism Treatment Study Results Send BioMarin Stock Skyward
BioMarin shares neared an all-time high after announcing positive results from a mid-stage study for its drug to treat the most common form of dwarfism. Read More
Thursday, June 18, 2015
Industry-leading performance, optimized distribution and reduced payload risks
Patented award-winning Golden Hour™ Technology and Credo ProEnvision™ track-and-trace software.
Safe transport of temperature-sensitive tissues, biologics, diagnostics, devices and vaccines for the

Thursday, June 18, 2015

Synergy Shares Rise

Shares of Synergy Pharmaceuticals jumped 47% on encouraging, late-state study results for its constipation drug. Read More

Thursday, June 18, 2015

Recipharm Acquires OnTarget Chemistry

Recipharm has completeted the acquisition of OnTarget Chemistry in Uppsala, Sweden. OnTarget Chemistry is a fast growing CRO company with a turnover in 2014 of close to SEK 29 million that is ... Read More

Metrics Contract Services Invests In Equipment

eClinicalOS™ Mobile App Breaks New Ground for Clinical Researchers

Intas Launches RAZUMAB

Alexza Amends ADASUVE® Commercial Partnership Agreements

Survey: Biopharmaceutical Deals to Set a Record in 2015

FDA Takes Action to Protect Consumers

Senator Probes Retailers on Dubious 'Brain' Supplements

Sandoz Launches Glatopa

SGS Life Science Services Opens New French Laboratory

Allergan Acquires Kythera

Catalent Expands Packaging Capabilities

Dwarfism Treatment Study Results Send BioMarin Stock Skyward

Industry-leading performance, optimized distribution and reduced payload risks

Synergy Shares Rise

Recipharm Acquires OnTarget Chemistry

Current Issue

July/August/September 2026

2026 Company Focus & Industry Reference Guide

2026 Company Focus & Industry Reference Guide

Subscriptions

Connect with Us

Sign Up for Our Newsletter